FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 31442 - Advisory Council on Blood Stem Cell Transplantation - Statutory (Congress Created)

GENERAL INFORMATION

Committee Name	Advisory Council on Blood Stem Cell Transplantation	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	31442
Original Establishment Date	12/20/2005	Committee Status	Chartered
Actual Termination Date		Committee URL	https://bloodcell.transplant.hrsa.gov/about/adv...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	19
Terminated This FY	No	Designated Fed Officer Position Title*	Branch Chief, BSCTB, Division of Transplantation, Health Systems Bureau
Merged This FY		Designated Federal Officer Prefix	Ms.
Current Charter Date	2/19/2023	Designated Federal Officer First Name*	Shelley
Date Of Renewal Charter	2/19/2025	Designated Federal Officer Middle Name
Projected Termination Date		Designated Federal Officer Last Name*	Grant
Exempt From Renewal*	No	Designated Federal Officer Suffix
Specific Termination Authority		Designated Federal Officer Phone*	(301) 443-8036
Establishment Authority*	Statutory (Congress Created)	Designated Federal Officer Fax*	301-594-6095
Specific Establishment Authority*	42 U.S.C. 274k	Designated Federal Officer Email*	sgrant@hrsa.gov
Effective Date Of Authority*	12/20/2005
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Non Scientific Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	Not Applicable
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	The ACBSCT was established to advise the Secretary of HHS on matters related to the activities of the C.W. Bill Young Cell Transplantation and the National Cord Blood Inventory Programs. The ACBSCT provides a consolidated, comprehensive source of expert, unbiased analysis and recommendations to the Secretary on the latest advances in the science of blood stem cell transplantation, including cord blood.
How is membership balanced?*	The Council is composed of up to 15 voting members representing marrow donor and transplant centers; cord blood banks; birthing hospitals; transplant recipients; persons waiting for transplants; family members of recipients; and members of the general public. The Council has 4 ex-officio, non-voting members.
How frequent & relevant are cmte mtgs?*	The Advisory Council shall convene at least two times each calendar year.
Why advice can't be obtained elsewhere?*	This expertise is not available within HHS.
Why close or partially close meetings?	N/A
Recommendation Remarks	The term end date for Filippo Milano was extended to 2/3/2025. The term end dates for Ann Richardson Berkey and Richard Maziarz were extended to 3/3/2025.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	Yes
Outcome Trust In Government	Yes	Action Reallocate Resources	No
Outcome Major Policy Changes	Yes	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	Yes	Action Other	No
Outcome Increased Customer Satisfaction	Yes	Action Comment	N/A
Outcome Implement Laws/Reg Requirements	Yes	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	N/A	Number Of Grants Recommended	0
Cost Savings*	None	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	While the ACBSCT's recommendations have focused on improvements to patient care through blood stem cell transplant and efficiency in the system, direct cost savings for the government have not been measured.	Grants Review Comment	N/A
Number Of Recommendations*	36	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	Currently, there are 33 recommendations; however, the Advisory Council recently made another three recommendations to the HHS Secretary that are being routed for review and clearance.	Access Agency Website	Yes
% of Recs Fully Implemented*	55.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	The Program and the community are engaged in discussions about the implementation of all recommendations.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	45.00%	Access Publications	No
% of Recs Partially Implemented Comment	The Program and the community are engaged in discussions about the implementation of all recommendations.	Access Other	No
Agency Feedback*	Yes	Access Comment	N/A
Agency Feedback Comment*	The Secretary of HHS acknowledges receipt of any recommendations. The public can obtain information on agency feedback at the ACBSCT website: https://bloodcell.transplant.hrsa.gov/about/advisory_council/index.html	Narrative Description*	HHS has a vital role in safeguarding and promoting public health by overseeing the operation of the C.W. Bill Young Transplantation Program and the National Cord Blood Inventory. The principal purpose of these programs is to make blood stem cells from adult donors and cord blood units available for patients who need a transplant to treat life-threatening conditions, such as leukemia, and who lack a suitably matched relative who can be the donor.

COSTS

1. Payments to Non-Federal Members*		1. Est Paymnts to Non-Fed Membrs Nxt FY*
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*
3. Payments to Federal Staff*		3. Estimated Payments to Federal Staff*
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs		10. Est. Other Costs Next FY*
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	3/14/2025 9:44 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Health Safety Treatment Medicine Diseases

Custom Links

Committee Level Reports